Compare MCI & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCI | SLP |
|---|---|---|
| Founded | 1971 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.4M | 326.7M |
| IPO Year | N/A | 1996 |
| Metric | MCI | SLP |
|---|---|---|
| Price | $17.78 | $18.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 36.4K | ★ 182.9K |
| Earning Date | 01-01-0001 | 04-09-2026 |
| Dividend Yield | ★ 8.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.82 | 0.26 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ $9.86 | $62.96 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $16.57 | $11.09 |
| 52 Week High | $23.00 | $21.01 |
| Indicator | MCI | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 56.47 | 68.24 |
| Support Level | $17.27 | $16.26 |
| Resistance Level | $18.08 | $19.29 |
| Average True Range (ATR) | 0.49 | 0.84 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 54.39 | 89.77 |
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.